PolyPeptide Group AG (SWX:PPGN)
Switzerland flag Switzerland · Delayed Price · Currency is CHF
27.75
+1.60 (6.12%)
Aug 14, 2025, 5:31 PM CET

PolyPeptide Group AG Ratios and Metrics

Millions CHF. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2018 - 2019
Period Ending
Aug '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2019
Market Capitalization
8639375778344,525-
Upgrade
Market Cap Growth
-29.49%62.30%-30.79%-81.57%--
Upgrade
Enterprise Value
8951,0026557994,381-
Upgrade
Last Close Price
26.1528.4017.5225.32136.52-
Upgrade
PE Ratio
---108.6692.36-
Upgrade
Forward PE
881.84147.50-26.8676.21-
Upgrade
PS Ratio
2.502.971.943.0015.47-
Upgrade
PB Ratio
2.792.801.632.0010.36-
Upgrade
P/TBV Ratio
2.912.921.702.0810.73-
Upgrade
P/FCF Ratio
28.40273.70----
Upgrade
P/OCF Ratio
6.6711.1717.00154.5776.11-
Upgrade
PEG Ratio
-2.532.536.252.92-
Upgrade
EV/Sales Ratio
2.603.172.202.8814.98-
Upgrade
EV/EBITDA Ratio
39.3758.41-24.4550.64-
Upgrade
EV/EBIT Ratio
---64.5262.70-
Upgrade
EV/FCF Ratio
29.46292.65----
Upgrade
Debt / Equity Ratio
0.340.290.330.080.070.29
Upgrade
Debt / EBITDA Ratio
4.574.61-0.870.340.86
Upgrade
Debt / FCF Ratio
3.4228.75---5.85
Upgrade
Asset Turnover
0.510.470.510.480.580.66
Upgrade
Inventory Turnover
2.062.182.311.781.761.80
Upgrade
Quick Ratio
0.730.901.091.042.040.81
Upgrade
Current Ratio
1.621.691.852.623.191.77
Upgrade
Return on Equity (ROE)
-10.05%-5.30%-12.81%1.84%15.78%19.16%
Upgrade
Return on Assets (ROA)
-0.62%-0.52%-3.34%1.34%8.68%8.13%
Upgrade
Return on Capital (ROIC)
-0.97%-0.77%-4.41%1.73%12.39%13.00%
Upgrade
Return on Capital Employed (ROCE)
---2.60%13.70%16.20%
Upgrade
Earnings Yield
-3.76%-1.96%-8.29%0.92%1.08%-
Upgrade
FCF Yield
3.52%0.36%-2.65%-8.25%-0.38%-
Upgrade
Dividend Yield
----0.22%-
Upgrade
Payout Ratio
---124.51%--
Upgrade
Buyback Yield / Dilution
-1.74%-0.10%0.11%-2.74%-7.08%-
Upgrade
Total Shareholder Return
--0.10%0.11%-2.74%-6.86%-
Upgrade
Updated Mar 1, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.